نتایج جستجو برای: zolpidem tartrate

تعداد نتایج: 3908  

2013

Lopressor, metoprolol tartrate USP, is a selective beta1-adrenoreceptor blocking agent, available as 50and 100-mg tablets for oral administration and in 5-mL ampuls for intravenous administration. Each ampul contains a sterile solution of metoprolol tartrate USP, 5 mg, and sodium chloride USP, 45 mg, and water for injection USP. Metoprolol tartrate USP is (±)-1­ (Isopropylamino)-3-[p-(2-methoxy...

Journal: :BMC Geriatrics 2008
Gary Zammit Sherry Wang-Weigand Xuejun Peng

BACKGROUND Computerized dynamic posturography (CDP) has been used to detect balance and stability impairments in adults of all ages. The goal of the current pilot study was to evaluate balance in healthy older adults after a middle-of-the-night awakening and to assess the ability of CDP to measure effects of bedtime zolpidem administration. METHODS Two studies used CDP to evaluate balance in ...

Journal: :The Journal of pharmacology and experimental therapeutics 2001
A Berson V Descatoire A Sutton D Fau B Maulny N Vadrot G Feldmann B Berthon T Tordjmann D Pessayre

Whereas alpidem is hepatotoxic, zolpidem is not. Despite closely related chemical structures, alpidem, but not zolpidem, is a peripheral benzodiazepine receptor (PBR) ligand, and is also more lipophilic than zolpidem. We compared their effects in isolated rat liver mitochondria and rat hepatocytes. Zolpidem did not affect calcium-induced mitochondrial permeability transition (MPT) in mitochondr...

Journal: :Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2008
Milton K Erman Gary Zammit Robert Rubens Kendyl Schaefer Thomas Wessel David Amato Judy Caron James K Walsh

STUDY OBJECTIVES To evaluate the polysomnographic efficacy and the safety of a range of doses of eszopiclone relative to placebo in patients with primary insomnia. Zolpidem 10 mg was included as an active control. METHODS This multicenter, randomized, crossover study enrolled patients aged 21-64 years meeting the DSM-IV criteria for primary insomnia (n = 65). Patients received 2 nights treatm...

Journal: :The Journal of pharmacology and experimental therapeutics 1997
C R Rush S Madakasira N H Goldman W L Woolverton J K Rowlett

In the present study, four non-drug-abusing humans were trained to discriminate between a hypnotic dose of pentobarbital, 100 mg, and placebo. After acquiring the pentobarbital-placebo discrimination, a range of doses of zolpidem, triazolam, pentobarbital and caffeine were tested to determine whether they shared discriminative stimulus effects with the training dose of pentobarbital, Zolpidem, ...

Journal: :The Journal of pharmacology and experimental therapeutics 2006
N R Mirza R J Rodgers L S Mathiasen

The zolpidem discriminative cue is mediated by GABA(A)-alpha1 receptors, whereas the chlordiazepoxide cue may be mediated via non-alpha1 GABA(A) receptors because compounds with selective affinity for GABA(A)-alpha1 receptors fully generalize to the former cue. We predicted that L-838,417 [7-tert-butyl-3-(2,5-difluorophenyl)-6-(2-methyl-2H-1,2,4-triazol-3-ylmethoxy)-1,2,4-triazolo[4,3-b]pyridaz...

Journal: :Acta Crystallographica Section C Crystal Structure Communications 1995

Journal: :Neuropharmacology 2015
David Nutt Sue Wilson Anne Lingford-Hughes Jim Myers Andreas Papadopoulos Suresh Muthukumaraswamy

A range of medications target different aspects of the GABA system; understanding their effects is important to inform further drug development. Effects on the waking EEG comparing these mechanisms have not been reported; in this study we compare the effects on resting MEG spectra of the benzodiazepine receptor agonist zolpidem, the delta sub-unit selective agonist gaboxadol (also known as THIP...

2015
Garrett C. Moraski Patricia A. Miller Mai Ann Bailey Juliane Ollinger Tanya Parish Helena I. Boshoff Sanghyun Cho Jeffery R. Anderson Surafel Mulugeta Scott G. Franzblau Marvin J. Miller

Zolpidem (Ambien, 1) is an imidazo[1,2-a]pyridine-3-acetamide and an approved drug for the treatment of insomnia. As medicinal chemists enamored by how structure imparts biological function, we found it to have strikingly similar structure to the antitubercular imidazo[1,2-a]pyridine-3-carboxyamides. Zolpidem was found to have antituberculosis activity (MIC of 10-50 μM) when screened against re...

2012
Yoshimichi Miyazaki Wataru Sako Kotaro Asanuma Yuishin Izumi Tetsuro Miki Ryuji Kaji

Although there are some newly developed options to treat dystonia, its medical treatment is not always satisfactory. Zolpidem, an imidazopyridine agonist with a high affinity on benzodiazepine subtype receptor BZ1 (ω1), was found to improve clinical symptoms of dystonia in a limited number of case reports. To investigate what subtype of dystonia is responsive to the therapy, we conducted an ope...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید